I always thought with 5+ letters I would be happy with $4-5 but $9-10 is definitely not fantasy land - I am giving mgt free rein on extra 400m shares to issue which gets us to 1.6B float - if they play it wisely they will be able to raise more than enough $ to keep this going into DME ph3 and beyond.
c.250M shares will be issued for oppie excise which will bring in close to $250M cash then we can probably issue about 150M at $2.5 for another $375M cash… total $600M+ extra cash which should be plenty to survive the lean times after ph3 readouts, FDA approval and to first revenues.
But yes - I am now more leaning towards a blockbuster buyout by BP so all these funding scenarios may be moot.
Add to My Watchlist
What is My Watchlist?